Literature DB >> 7350186

Biological activity of des-Asp1-angiotensin I in man.

T Kono, F Ikeda, F Oseko, H Imura, J Endo.   

Abstract

The biological activity of des-Asp1-angiotensin I (des-Asp1-AI) was studied in five normal men. An iv infusion of 300 ng (258 pmol)/kg.min des-Asp1-AI caused a remarkable rise in blood pressure, a decrease in PRA, and an increase in plasma aldosterone concentration. The pressor and steroidogenic actions of this dose of des-Asp1-AI were slightly less than those of 100 ng (111 pmol)/kg.min des-Asp1-angiotensin II [Angotensin III (AIII)] which we reported previously and were abolished by a single oral administration of 100 mg of a converting enzyme inhibitor, SQ 14225. These results indicate that in man, as in animals, a rise in blood pressure and an increase in plasma aldosterone concentration after an infusion of des-Asp1-AI are entirely due to the actions of AIII converted from this nonapeptide, and that the conversion rate of des-Asp1-AI to AIII in normal men is less than 43%. This is much less than the conversion rate of angiotensin I to angiotensin II. It seems unlikely that des-Asp1-AI has physiological significance in the human renin-angiotensin-aldosterone system.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7350186     DOI: 10.1210/jcem-50-1-40

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  4 in total

1.  Author's Reply to Srinivas: "A Single Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Orally Administered Des-Aspartate Angiotensin I in Healthy Subjects".

Authors:  Meng-Kwoon Sim; Kok-Onn Lee
Journal:  Drugs R D       Date:  2017-03

2.  Bioavailability of Orally Administered Des-Aspartate-Angiotensin I in Human Subjects.

Authors:  Kok-Onn Lee; Edmund Feng Tian; Martin Hui Cai; Hong Wang; Yiong-Huak Chan; Meng-Kwoon Sim
Journal:  Drugs R D       Date:  2018-03

3.  Vasoconstrictor and Pressor Effects of Des-Aspartate-Angiotensin I in Rat.

Authors:  Rosemary Wangensteen; Manuel Gómez-Guzmán; Inmaculada Banegas; Isabel Rodríguez-Gómez; Rosario Jiménez; Juan Duarte; Joaquín García-Estañ; Félix Vargas
Journal:  Biomedicines       Date:  2022-05-25

4.  A Single Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Orally Administered Des-Aspartate Angiotensin I in Healthy Subjects.

Authors:  Ko-Onn Lee; Chin-Meng Khoo; Balram Chowbay; Yiong-Huak Chan; Meng-Kwoon Sim
Journal:  Drugs R D       Date:  2016-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.